<DOC>
	<DOCNO>NCT03012841</DOCNO>
	<brief_summary>To demonstrate safety effectiveness Arctic Front Advance™ Freezor MAX® Cardiac CryoAblation Catheters treatment drug refractory recurrent symptomatic persistent atrial fibrillation .</brief_summary>
	<brief_title>STOP Persistent AF</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Documentation symptomatic persistent AF : Defined continuous episode lasting longer 7 day less 6 month document consecutive ECG recording Failure intolerance least one Class I III antiarrhythmic drug Age 18 ( old require local law ) 80 Left atrial diameter &gt; 5.0 cm ( anteroposterior ) Prior leave atrial ablation surgical procedure ( include leave atrial appendage closure ) Presence likely implant permanent pacemaker , biventricular pacemaker , loop recorder , type implantable cardiac defibrillator ( without biventricular pace function ) within 12 month Body mass index ( BMI ) ≥34 Presence pulmonary vein stent Presence preexist pulmonary vein stenosis Preexisting hemidiaphragmatic paralysis Presence cardiac valve prosthesis Moderate severe mitral valve regurgitation stenosis Any cardiac surgery , myocardial infarction , PCI / PTCA coronary artery stenting occur 3 month interval precede consent date Unstable angina NYHA Class IV congestive heart failure and/or document leave ventricular ejection fraction ( LVEF ) less 45 % measure acceptable cardiac testing ( e.g . TTE ) Primary pulmonary hypertension Rheumatic heart disease Thrombocytosis , thrombocytopenia Any condition contraindicate chronic anticoagulation Active systemic infection Hypertrophic cardiomyopathy Cryoglobulinemia Uncontrolled hyperthyroidism Any cerebral ischemic event ( stroke TIAs ) occur 6 month interval precede consent date Any woman know pregnant breastfeeding , woman child bear potential reliable form birth regulation method abstinence Life expectancy less one year Current anticipate participation clinical trial drug , device biologic duration study preapproved Medtronic Known allergy hypersensitivities adhesive Known drug alcohol dependency Unwilling unable comply fully study procedure followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>